Presentation Information
[S7-3]Maximizing Clinical Utility of Moderate-Penetrance Variants: Transitioning from Risk Assessment to Treatment Selection
Tomohiro Kondo1,2 (1. Department of Clinical Oncology, Kyoto University Hospital, 2. Real-World Data R&D, Graduate School of Medicine, Kyoto University)
Password required to view
Log in
or